| scholarly article | Q13442814 |
| P50 | author | Jian-Dong Huang | Q70624280 |
| P2093 | author name string | Bin Yu | |
| Godfrey Chi-Fung Chan | |||
| Shing Chan | |||
| Bo-Tao Ning | |||
| Jian-Liang Chan | |||
| P2860 | cites work | Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma | Q24602657 |
| In vivo gene regulation in Salmonella spp. by a salicylate-dependent control circuit | Q28222502 | ||
| Exploiting tumour hypoxia in cancer treatment | Q28264146 | ||
| Toll-like receptor expression in normal ovary and ovarian tumors | Q28307970 | ||
| A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group | Q33370628 | ||
| Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha | Q33495169 | ||
| Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies | Q33877024 | ||
| High-throughput screening for salmonella avirulent mutants that retain targeting of solid tumors | Q33920984 | ||
| Treatment resistance of solid tumors: role of hypoxia and anemia | Q34579410 | ||
| TLR4 activates NF-κB in human ovarian granulosa tumor cells | Q35056554 | ||
| Bacteria as tumour-targeting vectors | Q35215803 | ||
| How frequent is spontaneous remission of neuroblastomas? Implications for screening | Q35981430 | ||
| Genetically modified "obligate" anaerobic Salmonella typhimurium as a therapeutic strategy for neuroblastoma. | Q35984126 | ||
| Explicit hypoxia targeting with tumor suppression by creating an "obligate" anaerobic Salmonella Typhimurium strain | Q36001671 | ||
| Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumours | Q36656933 | ||
| Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack. | Q37002943 | ||
| Neuroblastoma: biology, prognosis, and treatment | Q37683919 | ||
| Pharmacotherapy of neuroblastoma | Q37735199 | ||
| Salmonella-allies in the fight against cancer | Q37762990 | ||
| Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines | Q39513114 | ||
| Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model | Q39822325 | ||
| Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo | Q40171422 | ||
| Toll-like receptors on tumor cells facilitate evasion of immune surveillance | Q40409088 | ||
| Toll receptor-mediated regulation of NADPH oxidase in human dendritic cells. | Q40501902 | ||
| ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. | Q40552048 | ||
| Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior | Q40565424 | ||
| Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant interleukin 2. | Q41238346 | ||
| The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. | Q41736480 | ||
| Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice | Q43677697 | ||
| A mechanism for neutrophil-mediated lysis of human neuroblastoma cells | Q46185149 | ||
| A fluorescent orthotopic mouse model for reliable measurement and genetic modulation of human neuroblastoma metastasis | Q46839226 | ||
| Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cells | Q46940456 | ||
| Containment of tumor-colonizing bacteria by host neutrophils | Q50062621 | ||
| Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors | Q50102730 | ||
| Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium | Q50120814 | ||
| Tumor-targeted Salmonella as a novel anticancer vector | Q50133173 | ||
| Recent advances in neuroblastoma | Q56637924 | ||
| Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group | Q57734267 | ||
| Spontaneous regression of cancer: preliminary report | Q74239324 | ||
| Spontaneous regression of localized neuroblastoma detected by mass screening | Q74463733 | ||
| P433 | issue | 9 | |
| P921 | main subject | Salmonella Typhimurium | Q166491 |
| neuroblastoma | Q938205 | ||
| P304 | page(s) | 1609-1618 | |
| P577 | publication date | 2017-06-03 | |
| P1433 | published in | Journal of Cancer | Q6294901 |
| P1476 | title | Treatment of Neuroblastoma with an Engineered "Obligate" Anaerobic Salmonella typhimurium Strain YB1 | |
| P478 | volume | 8 |
Search more.